MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.

There is no fulltext present in this item.

Title:	MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
Author(s):	Prange, K.H.M.; Mandoli, A.; Kuznetsova, T.; Wang, S.Y.; Sotoca, A.M.; Marneth, A.E.; Reijden, B.A. van der ; Stunnenberg, H.G; Martens, J.H.
Publication year:	2017
Source:	Oncogene, vol. 36, iss. 23, (2017), pp. 3346-3356
ISSN:	0950-9232
DOI:	https://doi.org/10.1038/onc.2016.488
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/175065
Display more details
Subject:	Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Laboratory Medicine
Journal title:	Oncogene
Volume:	vol. 36
Issue:	iss. 23
Page start:	p. 3346
Page end:	p. 3356